Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 7 of 7 Projects
Project # Contact PI Funding Organization Fiscal Year
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
Novel diagnostic CSF biomarkers for pathological subtypes of FTD
20141204-Teunissen-2014 Teunissen, Charlotte Alzheimer's Drug Discovery Foundation 2014
Identification of novel discriminatory CSF biomarkers for different FTD subtypes by proteomics
20111106 AFTD-Teunissen-2011 Teunissen, Charlotte Alzheimer's Drug Discovery Foundation 2011
TDP-43 and tau as cerebrospinal fluid biomarkers to discriminate frontotemporal dementia subtypes
20101207 AFTD-Verbeek-2010 Verbeek, Marcel Alzheimer's Drug Discovery Foundation 2010
High-throughput-screening for compounds against Aph1B-gamma-secretase
290701-De Strooper-2009 De Strooper, Bart Alzheimer's Drug Discovery Foundation 2009
Drug Discovery for Progranulin-Mediated Frontotemporal Lobar Degeneration
291208 AFTD-Van Damme-2009 Van Damme, Philip Alzheimer's Drug Discovery Foundation 2009